Condition
Fetal Growth Abnormality
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 77/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
67% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 3 (1)
Trial Status
Completed2
Terminated1
Unknown1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT03266198Completed
Fetal 3D Study (Fetal Body Composition and Volumes Study)
NCT03857659Not ApplicableTerminatedPrimary
Serial Third Trimester Abdominal Circumference and Amniotic Fluid Measurements Versus Routine Care
NCT03962153CompletedPrimary
Ultrasonographic Parameters for Fetal Weight Prediction
NCT03230162Phase 3UnknownPrimary
Sildenafil Versus Low Molecular Weight Heparin in Fetal Growth Restriction Treatment
Showing all 4 trials